UCB

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, with a strong emphasis on research and development to address unmet patient needs. Established in 1928, UCB's mission is encapsulated in their slogan, "Inspired by patients. Driven by science." The company's dedication to making a difference for individuals suffering from severe diseases is reflected in its innovative approach and commitment to pushing boundaries. With approximately 9000 employees spread across 40 countries, UCB boasts a €5.3 billion global revenue as of 2023, indicating substantial financial strength. Its key specialties in neurology and immunology contribute to its promising pipeline of novel molecules. UCB’s investment of more than 25% of its revenue into scientific research underscores its dedication to driving breakthrough solutions for patients. The company's approach is deeply rooted in empathetic connections with patients and their families, aiming to gain new perspectives that drive innovation and offer hope for transformative therapies. UCB's commitment to leveraging its talents in unlocking innovation and setting new industry standards ensures its position at the forefront of addressing severe diseases. In sum, UCB has demonstrated its commitment to driving impactful change in the healthcare industry, earning its reputation as an industry leader with a focus on patient-centric innovation and a robust financial outlook.